Jesse @OzGrants.Au
@noparkingtues.bsky.social
Global consultant. Grant strategist. Driving bold, high-impact solutions.
I had the pleasure of joining Impact Boom for a conversation on social innovation, housing justice and the role of community-led partnerships in creating systems-level change & why trust, equity & grant strategy matter in achieving real impact.
Have a listen here: www.impactboom.org/blog/2025/07...
Have a listen here: www.impactboom.org/blog/2025/07...
change.trust
July 9, 2025 at 3:33 AM
I had the pleasure of joining Impact Boom for a conversation on social innovation, housing justice and the role of community-led partnerships in creating systems-level change & why trust, equity & grant strategy matter in achieving real impact.
Have a listen here: www.impactboom.org/blog/2025/07...
Have a listen here: www.impactboom.org/blog/2025/07...
A twice-yearly HIV prevention drug, lenacapavir, could help end the HIV pandemic — but only if it's priced fairly. It can be mass-produced for $25/year. Charging $25,000 is 1,000x that. Low cost = global access = lives saved. #HIVPrevention #GlobalHealthJustice #AccessForAll
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
www.theguardian.com
June 23, 2025 at 7:49 AM
A twice-yearly HIV prevention drug, lenacapavir, could help end the HIV pandemic — but only if it's priced fairly. It can be mass-produced for $25/year. Charging $25,000 is 1,000x that. Low cost = global access = lives saved. #HIVPrevention #GlobalHealthJustice #AccessForAll